MILNACIPRAN EG 25 mg, hard capsule 56 capsules
Active ingredients: Milnacipran hydrochloride, Milnacipran
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule56 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MILNACIPRAN EG 25 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- plaquette(s) aluminium PVC PVDC de 56 gélule(s)
- Marketing authorisation holder
- DOUBLE-E PHARMA (IRLANDE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 4 Nov 2020
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60068034CIP73015704CIP133400930157046Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MILNACIPRANgélule | 21,77 mg · une gélule | FT |
| CHLORHYDRATE DE MILNACIPRANgélule | 25 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.